Wambeke David J. 4
4 · DiaMedica Therapeutics Inc. · Filed Apr 11, 2023
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Purchase
Voting Common Shares, no par value per share
2023-04-10$1.60/sh+468,750$750,000→ 468,750 total - Award
Stock Option (right to buy)
2023-04-10+140,000→ 140,000 totalExercise: $1.57Exp: 2033-04-09→ Common Shares (140,000 underlying)
Footnotes (1)
- [F1]This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date.